What the next 50 years of reproductive rights activism can learn from the last 50
By Felicia Kornbluh,
The Washington Post
| 01. 20. 2023
In June 1973, the Southern Poverty Law Center began publicizing a case it was pursuing in defense of two Black children from Alabama, Minnie Lee and Mary Alice Relf. The Relf sisters, 14 and 12 years old, had been sterilized on the recommendation of a nurse employed by the federal government. The girls’ mother, who reportedly could not read or write, signed consent forms for the sterilization of her two young daughters with an “X” and said later that she thought she was authorizing a form of reversible birth control, not a permanent removal of her daughters’ reproductive capacity. Relf v. Weinberger burst onto the scene just six months after Supreme Court Justice Harry A. Blackmun published his opinion for the majority in Roe v. Wade on Jan. 22, 1973, 50 years ago this week. This was a time of celebration for most feminists, and justly so: Their movement, working ardently at the grass roots and uniting across many lines of difference, had persuaded the nation’s highest court to recognize people’s need to make autonomous choices about whether to end...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...